Skip to content

Magnetic Endoscope Imaging in Colonoscopy: Influence on Propofol Dosage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02121704
Acronym
MEXICO
Enrollment
334
Registered
2014-04-23
Start date
2014-05-31
Completion date
2015-11-30
Last updated
2015-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed Conscious Sedation During Procedure

Keywords

Sedation, Colonoscopy, Propofol, Scope guide

Brief summary

Magnetic Endoscope Imaging (MEI) is an optional tool which can be switched on at the beginning of colonoscopy. MEI works by creating an electromagnetic field of very low intensity. By that the position of the endoscope can be displayed virtually on a monitor. The use of MEI has been shown to reduce the formation of loops and to ease the removal of existing loops during the investigation. Furthermore, as loops favour the occurrence of pain when the scope is moved forward, patients who underwent colonoscopy with MEI reported less pain at the end of the procedure. Sedation is used widely during colonoscopy for it has improved the tolerability of the investigation. Most of the patients demand for sedation. In Germany Propofol is recommended as the first-line sedative when endoscopy it is performed in an outpatient setting. The use of Propofol involves the danger of respiratory complications. One reason for the application of Propofol doses is the occurrence of pain during the investigation. We hypothesized that if MEI is used and if loops can be avoided sufficiently lower Propofol doses would be needed. We therefore planned this prospective controlled trial.

Interventions

DEVICEMagnetic Endoscope Imaging (Scope Guide)

Sponsors

Olympus
CollaboratorINDUSTRY
Technical University of Munich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* medical indication for colonoscopy * age \>18 years * written consent given by patient * investigation under sedation with propofol

Exclusion criteria

* application of any other sedative than propofol * age \< 18 years * pregnant women * patients denying written consent * ASA class IV, V and VI * indication for colonoscopy: emergency (e.g. severe rectal bleeding) * allergy to propofol * pre-existing hypotension, bradycardia or hypoxemia * history of sedation accidents

Design outcomes

Primary

MeasureTime frameDescription
Propofol doseup to one day (participants will be followed for the duration of hospital stay or outpatient treatment, an expected average of 1 day)At the end of colonoscopy total dose of Propofol applicated will be assessed.

Secondary

MeasureTime frameDescription
Hypoxemiaup to 1 day (participants will be followed for the duration of hospital stay or outpatient treatment, an expected average of 1 day)Oxygen saturation will be measured for the duration of colonoscopy/hospital stay.
Adenoma detection rateup to one day

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026